All Pharma News
Bristol Myers Squibb Completes Acquisition of RayzeBio

Bristol Myers Squibb Completes Acquisition of RayzeBio
BUSINESSWIRE
26 Feb 2024
Share Share
Bristol Myers Squibb Announces Expiration of RayzeBio Tender Offer

Bristol Myers Squibb Announces Expiration of RayzeBio Tender Offer
BUSINESSWIRE
23 Feb 2024
Share Share
Bristol Myers Squibb and RayzeBio Announce Expiration of HSR Act Waiting Period

Bristol Myers Squibb and RayzeBio Announce Expiration of HSR Act Waiting Period
BUSINESSWIRE
12 Feb 2024
Share Share
BMS beat 2 other pharmas in bid for RayzeBio

BMS beat 2 other pharmas in bid for RayzeBio
FIERCE BIOTECH
25 Jan 2024
Share Share
Bristol Myers to buy RayzeBio for $4.1 billion in targeted cancer therapy push

Bristol Myers to buy RayzeBio for $4.1 billion in targeted cancer therapy push
REUTERS
27 Dec 2023
Share Share
RayzeBio Reports Third Quarter 2023 Financial Results

RayzeBio Reports Third Quarter 2023 Financial Results
GLOBENEWSWIRE
13 Nov 2023
Share Share
RayzeBio to Participate in Upcoming Investor Conferences in November 2023

RayzeBio to Participate in Upcoming Investor Conferences in November 2023
GLOBENEWSWIRE
06 Nov 2023
Share Share
RayzeBio Appoints Industry Leader Tim Van Hauwermeiren to Its Board of Directors

RayzeBio Appoints Industry Leader Tim Van Hauwermeiren to Its Board of Directors
GLOBENEWSWIRE
01 Nov 2023
Share Share
FDA selects RayzeBio to Participate in the Inaugural CDRP Program

FDA selects RayzeBio to Participate in the Inaugural CDRP Program
GLOBENEWSWIRE
24 Oct 2023
Share Share
RayzeBio to Present at European Society for Medical Oncology (ESMO) Congress

RayzeBio to Present at European Society for Medical Oncology (ESMO) Congress
GLOBENEWSWIRE
18 Oct 2023
Share Share